• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD UNKN BIRMINGHAM HIP MODULAR HEAD (BHMH) HEMI; PROSTHESIS, HIP, HEMI-, FEMORAL, METAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD UNKN BIRMINGHAM HIP MODULAR HEAD (BHMH) HEMI; PROSTHESIS, HIP, HEMI-, FEMORAL, METAL Back to Search Results
Catalog Number 74122552
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Metal Related Pathology (4530); Swelling/ Edema (4577)
Event Date 11/11/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that the patient underwent a revision surgery on november 11th associated to pain and elevated ion levels in the blood.
 
Manufacturer Narrative
It was reported that left hip revision surgery was performed.As of today, the implanted devices, all of which were used in treatment, and additional information have been requested for this complaint but have not become available.As no device part and batch numbers were provided for investigation, a complaint history review, manufacturing record review and device labelling / ifu review could not be performed.If more information is received, this investigation will be reopened.A risk management review was performed.No additional risks were identified as result of the reported event and no further actions are required at this time.The available medical documents were reviewed.Although the reported elevated metal ions, pseudotumor and trunnionosis may be consistent with metal debris, without the supporting lab results and/or the analysis of the explanted components, the root cause of the reported elevated ions, pseudotumor and trunnionosis cannot be confirmed and it cannot be concluded that the reported clinical reactions were associated with a mal-performance of the implant.The patient impact beyond the revision and expected transient post-op convalescence period cannot be determined.Without return of the actual devices or further information we cannot further investigate or confirm the details supplied in this complaint, and our investigation remains inconclusive.If the products or additional information become available in the future, this case will be reopened.No preventative or corrective action has been initiated as a result of this investigation.
 
Event Description
It was reported that the patient underwent revision surgery of the right hip on (b)(6) 2020 due to toxic levels of cobalt and chromium, secondary to trunionosis and, additionally, painful hips showed joint effusions on mri.The metallic femoral head was explanted and replaced with a dual mobility inset and an oxonium femoral head.The patient was returned to the pacu without complication.
 
Manufacturer Narrative
Sections a2, a3, b3, b5, d3, d4, d10 and h6 were updated according to the new information received.Internal complaint reference number: case (b)(4) section d2 was corrected according to the new information received.
 
Manufacturer Narrative
H3, h6: it was reported that right hip revision surgery was performed.During the revision, the hemi head and modular sleeve were explanted.The acetabular cup and stem remained implanted.A hemi head (part no.74122552, batch no.Unknown) and a modular sleeve (part no.Unknown, batch no.Unknown) used in treatment were received for investigation.As of today, additional information has been requested for this complaint but has not become available.Without definitive part/lot numbers a complete complaint history review cannot be performed for the acetabular cup, stem or modular sleeve involved.Without a definitive batch number, a complete complaint history review cannot be performed for the hemi head.A review of the historical complaints data for the hemi head was performed using part numbers and the reported failure modes to evaluate patterns of repeated failures or defects in a timeframe of 12 months prior to the date in which the incident was reported.No other similar complaints have been identified for the part number and the reported failure mode in this timeframe.As no device batch numbers were provided for investigation, a manufacturing record review and device labelling / ifu review could not be performed.However, the released devices would have met manufacturing specifications at the time of production.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.Visual inspection was performed on the returned devices.Fine scratches and discoloration were observed on the bearing surface of the hemi head.Surface texture change and discoloration were observed on the internal sleeve taper.Wear analysis was performed to review linear wear on the bearing surface of the hemi head.The wear images identified a wear patch on the bearing surface of the hemi head.Maximum linear wear for the hemi head was 10.1m.Measurement of the vertical straightness profile of the internal sleeve taper showed material loss to a maximum depth of 128.0m.Based on historic wear data, after 9 years in vivo, the measured linear wear on the bearing surface of the head is in line with the expected head wear for a non-edge loaded smith and nephew large diameter metal-on-metal device.Material loss was measured on the internal taper of the sleeve.The available medical documents were reviewed.Although the reported elevated metal ions and pseudotumor may be consistent with metal debris; the root cause of the reported elevated ions and pseudotumor cannot be confirmed and it cannot be concluded that the reported clinical reactions were associated with a mal performance of the implant.The patient impact beyond the revision and expected transient post-operative convalescence period cannot be determined.Without additional information we cannot advance the investigation or confirm this complaint; our investigation remains inconclusive, and a definitive root cause cannot be determined.Based on the limited information provided we are unable to speculate on specific factors known to contribute to the alleged fault.Should additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKN BIRMINGHAM HIP MODULAR HEAD (BHMH) HEMI
Type of Device
PROSTHESIS, HIP, HEMI-, FEMORAL, METAL
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK  CV31 3HL
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK   CV31 3HL
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key11099856
MDR Text Key224519854
Report Number3005975929-2020-00530
Device Sequence Number1
Product Code KWL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 12/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number74122552
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/30/2021
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/10/2020
Initial Date FDA Received12/31/2020
Supplement Dates Manufacturer Received01/26/2021
08/12/2021
12/21/2021
Supplement Dates FDA Received01/27/2021
08/17/2021
12/23/2021
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNK BIRMINGHAM HIP MODULAR HEAD SLEEVED MODULAR; UNKN ANTHOLOGY HIP IMPLANT
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age59 YR
Patient SexMale
-
-